"We are excited to add Norepinephrine to expand our list of products that help bring flexibility to the hospital IV needs," said Joseph Cosgrove, Chairman, President, and CEO of Pentec Health. Mr.
PHILADELPHIA, Aug. 28, 2018 /PRNewswire-PRWeb/ -- Pentec Health, Inc., an established leader in patient-specific and sterile compounding (503A), announced the availability of multiple products using ...
The Daily Overview on MSN
Eli Lilly cuts Zepbound weight-loss vial prices on its DTC site
Eli Lilly is cutting what self-paying patients shell out for its blockbuster obesity drug Zepbound when they buy single-dose ...
In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...
CHARLESTON, S.C. (WCBD) – Lowcountry hospitals say they’re not wasting any vials of the COVID-19 vaccine as the race to vaccinate ramps up. It’s all about timing. Dr. Robert Oliverio, the Chief ...
Closed-vial technology is an alternative to traditional glass vial filling that reduces the risk of contamination for the patient, simplifies the filling process, and provides easier handling for ...
The authors present an aseptic-filling process for freeze-dried liquids using the closed-vial technology. Thilly and coauthors introduced closed-vial filling systems, called "Crystal" technology, for ...
PHILADELPHIA, Jan. 8, 2019 /PRNewswire-PRWeb/ -- Pentec Health, Inc., an established leader in sterile compounding, announced that they now have Norepinephrine in their patent-pending vial-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback